
COVID-19 Return To Work: Managing Safety, Data And Privacy For A Secure Workplace
View presentation slides from the webinar on managing safety, data, and privacy for a secure workplace as companies return to work amid COVID-19.
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.

View presentation slides from the webinar on managing safety, data, and privacy for a secure workplace as companies return to work amid COVID-19.

This document identifies new laws and policies that should remain in place at the conclusion of the PHE.

AdvaMedDx® developed the VALID Assessment Framework as a tool to analyze the legislation.

View a flow chart of the evaluation process.

The Chinese government announced a process to export particular devices without NMPA approval.
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.

Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.

This guidance helps member companies support decision-making and mitigate compliance risks.

This infographic depicts the process of COVID-19 diagnostic tests from patient sample to test results.

ABHI and AdvaMed® will coordinate activities.